Health TrialsbyHealthPanel

CRESCENDO: ChildREn's muSiC ENhancement in Cochlear Implant Users

ConditionsCochlear ImplantHearing Loss
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-19
SponsorSeoul National University Hospital

About this trial

This exploratory, single-center, single-arm study investigates the impact of a 12-week Multimodal Acoustic Therapy (MAT) intervention followed by a 12-week follow-up period on both objective and subjective auditory perception in pediatric cochlear implant users.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Individuals with cochlear implants

Korean patients aged 10 to 19 years

Capable of using a smartphone

Scored ≤80% on MCI pre-assessment

Disqualifiers

Has systemic medical conditions (e.g., cancer, stroke) that limit daily functioning

Has intellectual disability, congenital malformation, or other neurological disorders affecting language or cognitive abilities

Has diagnosed emotional disorders such as depression or anxiety

Primarily uses sign language for daily communication

Trial design

Design model

Single group

Treatments tested in this trial

  • Mobile Auditory Rehabilitation

    Device

    Mobile Application for Auditory Rehabilitation

Treatment groups

25 Participants
are divided into 1 treatment group
Group A: InterventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Melody Contour Identification (MCI)

Participants complete a melody contour identification task in which they listen to brief melodic sequences and select the contour pattern (e.g., rising, falling, flat). Performance is quantified as the percentage of correctly identified contours (% correct). Higher scores indicate better melody contour perception.

Time frame
12 weeks

Secondary outcomes

1

Music-Related Quality of Life (MuRQoL)

Each item is rated on a 1-5 Likert scale, and domain scores may be converted to a normalized 0-100 scale. Higher scores indicate better music-related quality of life.

Time frame
12 weeks
2

Parents' Evaluation of Aural/Oral Performance of Children (PEACH)

Auditory performance in everyday listening situations will be evaluated using the Parents' Evaluation of Aural/Oral Performance of Children (PEACH) questionnaire. Parents rate their child's functional auditory behaviors across quiet and noisy environments. Scores are converted to a percentage (0-100%), with higher scores indicating better auditory performance. The PEACH is a parent-proxy assessment tool, consistent with its standard scoring procedure.

Time frame
12 weeks
3

Quality of Life - Cochlear Implants (Parent-Proxy Report)

Quality of life specific to pediatric cochlear implant users will be assessed using the Quality of Life - Cochlear Implants (CI-QOL) questionnaire. This is a parent-proxy reported measure, in which parents rate their child's auditory-related daily functioning, communication abilities, social participation, and emotional well-being. Scores range from 0 to 100, with higher scores indicating better quality of life.

Time frame
12 weeks
4

Emotional Prosody Perception Test (EPP)

Performance will be reported as the percentage. Higher percentages indicate better emotional prosody perception.

Time frame
12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Seoul National University Hospital

Lead sponsor

BELL Therapeutics Inc.

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: